首页> 外国专利> NEW PHARMACEUTICAL COMPOSITION, WHICH POSSESSES THE ANTI-HYPERTENSIVE ACTION

NEW PHARMACEUTICAL COMPOSITION, WHICH POSSESSES THE ANTI-HYPERTENSIVE ACTION

机译:具有抗高血压作用的新药物成分

摘要

1.Farmatsevticheskaya composition having antihypertensive activity, characterized in that it comprises a selective angiotensin II receptor antagonist type diuretic and a sulfonamide or a pharmaceutically acceptable salt thereof and optionally pharmaceutically acceptable excipients, wherein a selective antagonist of angiotensin II receptor type is candesartan, or a pharmaceutically acceptable salt and sulfonamide diuretic is indapamide or a pharmaceutically acceptable soli.2. A pharmaceutical composition according to claim 1, characterized in that it has the following ratio of the active components, mg: 3. A pharmaceutical composition according to claim 1, wherein as adjuvants chosen: lactose monohydrate, colloidal silicon dioxide, corn starch, magnesium stearate, sodium carmellose, gipromelloza.4. A pharmaceutical composition according to claim 1, characterized in that it is made in the form of capsules, tablets and / or pills, film-coated.
机译:1.具有抗高血压活性的Farmatsevticheskaya组合物,其特征在于其包含选择性血管紧张素II受体拮抗剂利尿剂和磺酰胺或其药学上可接受的盐以及任选的药学上可接受的赋形剂,其中血管紧张素II受体类型的选择性拮抗剂为坎地沙坦,或药学上可接受的盐和磺酰胺利尿剂是吲达帕胺或药学上可接受的溶液。2。 2.根据权利要求1的药物组合物,其特征在于其具有以下比例的活性成分,mg:3。3.根据权利要求1的药物组合物,其中作为佐剂选择:乳糖一水合物,胶体二氧化硅,玉米淀粉,硬脂酸镁。 ,羧甲基纤维素钠,吉普洛美唑4。 2.根据权利要求1所述的药物组合物,其特征在于,其被制成薄膜衣的胶囊,片剂和/或丸剂的形式。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号